Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay

Pfizer

Status: Completed

Conditions: Healthy

Treatments: Procedure: Large volume blood draw

Study type: Interventional

Funder types: Industry

Identifiers

NCT00508950

6115A1-1000

B1851075 (Other Identifier)

Details and patient eligibility

About

The study will identify healthy adults who have been vaccinated against pneumococcus, and collect blood for the purpose of developing laboratory assays.

Full description

Collect serum with antibody levels capable of killing pneumococcal bacteria from healthy prevaccinated adults to develop OPA assays for the 13 serotypes in 13-valent pneumococcal conjugate vaccine.

Enrollment: 152 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy adults 18-70 years of age
• Must have received 23vPS pneumococcal vaccine

Exclusion criteria

• Bleeding diathesis
• Pregnancy
• Chronic disease which could be worsened by donating blood
• Receipt of blood, blood products or immune globulin within six months

Trial design

152 participants in 1 patient group

All subjects

Other group

Description:

All subjects

Treatment:

Procedure: Large volume blood draw